Real-World Breast Cancer Patient Follow-Up Practices by Medical Oncologists in India-A Survey Report [0.03%]
印度医学肿瘤学家的现实世界乳腺癌患者随访实践-调查报告
Amol Patel,Vineet Govinda Gupta,Bhupesh Guleria et al.
Amol Patel et al.
Amol PatelBackground In India, breast cancer patients' post-treatment follow-up practices are not known. We did this survey to understand how the breast cancer patients are followed-up and tried to explore the challenges associated with it....
Prognostic Factors of Granulosa Cell Tumors: A Retrospective Study in a Tertiary Care Cancer Centre of Eastern India [0.03%]
东方印度三级护理癌症中心颗粒细胞瘤预后因素的回顾性研究
Rohini V Kulkarni,Bhagyalaxmi Nayak,Jita Parija et al.
Rohini V Kulkarni et al.
Bhagyalaxmi NayakBackground and Aims The main objective of this study was to analyze the clinicopathological profile and prognostic factors of granulosa cell tumor (GCT). Method All the cases of ovarian cancer which were seen at our institu...
Nivolumab in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck: A Tertiary Cancer Center Experience [0.03%]
尼伏单抗在头颈部鳞状细胞癌复发/转移患者中的疗效观察：一家三级癌症中心的经验
Ananya Pareek,Apurva A Patel,Mukesh Kumar et al.
Ananya Pareek et al.
Apurva A. PatelAnanya PareekBackground Immunotherapy is a proven therapeutic option in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) after platinum therapy. At present, there are no published Indian data regarding a...
A Study of Head and Neck Cancer Patients with Reference to Tobacco Use, Gender, and Subsite Distribution [0.03%]
吸烟、性别和肿瘤部位在头颈部鳞癌中的分布特点分析研究
Richa Chauhan,Vinita Trivedi,Rita Rani et al.
Richa Chauhan et al.
Richa ChauhanContext Head and neck cancer (HNC) is very common in India, constituting 30% of all the cancers because of the widespread use of tobacco across India. The prevalence and pattern of tobacco use vary in different regions and stat...
Oral Oncology and Reconstructive Surgery Fellowship Training Programs in India-A Trainee Perspective [0.03%]
印度口腔肿瘤学与重建外科培训项目-一名受训者视角
Sumedha Mohan,Gourav Popli,Kshitij Aggarwal
Sumedha Mohan
Morphology and Immunoprofiling of Benign Lymphoid Aggregates in Bone Marrow Biopsies of Lymphoma Patients [0.03%]
淋巴瘤患者骨髓活检标本中良性淋巴集落的形态和免疫表型分析
Supreet Kaur Kalra,Sankalp Sancheti,Puneet Kaur Somal et al.
Supreet Kaur Kalra et al.
Totally Implantable Venous Access Device (Chemoport) in Oncology: Study of 168 Polyurethane Chemoport Catheter System [0.03%]
肿瘤科临床应用全植入式静脉输液港(化疗港)的实践研究——168例聚氨酯材质化疗港系统的临床分析
Gyanendra Swaroop Mittal,Deepak Sundriyal,Niranjan B Naik et al.
Gyanendra Swaroop Mittal et al.
Background Chemoport (totally implantable venous access device) and its catheter system are used to administer long-term chemotherapy in cancer patients. The objective of this study was to analyze the complications associated with chemoport...
Chemotherapy-Associated Pulmonary Toxicity-Case Series from a Single Center [0.03%]
单中心化疗相关性肺毒性病例系列分析
Tilak Tvsvgk,Ajay Handa,Kishore Kumar et al.
Tilak Tvsvgk et al.
Background Pulmonary toxicity due to chemotherapeutic agents can occur with many established and new drugs. Strong clinical suspicion is important as the clinical presentation is usually with nonspecific symptoms like cough, dyspnea, fever,...
Kajal Shah,Harsha Panchal,Apurva Patel
Kajal Shah
Myeloid sarcoma (MS) is a malignant extramedullary tumor consisting of immature cells of myeloid origin. It may precede, present concurrently or follow acute myeloid leukemia (AML) in de novo case or may also be present and might be the onl...
A Retrospective Cohort Study of Upfront Nilotinib in Chronic Myeloid Leukemia: A Single-Center Experience [0.03%]
伊马替尼治疗失败的慢性髓性白血病患者中尼洛替尼一线治疗的回顾队列研究：单中心经验
Reema Singh,Jyotsna Kapoor,Rayaz Ahmed et al.
Reema Singh et al.
Context Nilotinib is a second-generation BCR-ABL1 tyrosine kinase inhibitor used in the treatment of chronic myeloid leukemia (CML). Aims We aim to evaluate the responses and safety of upfront Nilotinib therapy in Indian CML patients. Setti...